Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Research Article
  • Published:

Telomerized presenescent osteoblasts prevent bone mass loss in vivo

Gene Therapy volume 11, pages 909–915 (2004)Cite this article

A Corrigendum to this article was published on 07 February 2006

Abstract

Previously, we showed that human osteoblasts expressing the human telomerase reverse transcriptase (hTERT) gene exhibited specific survival advantages – the result of breaching the replicative senescence barrier and maintaining the phenotypic and functional properties of primary osteoblasts in vitro over the total replicative capacity of primary osteoblasts. We postulated that rejuvenated osteoblasts may have a potential to correct bone loss or osteopenia in age-related osteoporotic diseases. In the present study, we studied whether telomerized presenescent osteoblasts prevent bone mass loss in vivo. After obtaining the informed consent from a patient with osteoarthritis who underwent the arthroplastic knee surgery, osteoblastic cells were isolated from donor bone sample. We transfected the gene encoding hTERT into human osteoblastic cells. Human bone fragments from a donor were incubated with human hTERT-transfected presenescent (in vitro aged) osteoblasts or mock-transfected presenescent osteoblasts in culture medium containing Matrigel. We subcutaneously implanted human bone fragments with telomerized presenescent osteoblasts or primary presenescent osteoblasts as three-dimensional Matrigel xenografts in severe combined immunodeficiency (SCID) mice (each group: six mice) and analyzed the grafts at 6 weeks after implantation. We also determined whether telomerized osteoblasts affect the bone-forming capacity in vivo, using a well-established mouse transplantation model in which ceramic hydroxyapatite/tricalcium phosphate particles are used as carrier vehicle. Telomerized presenescent osteoblasts were rejuvenated, and maintained the functional properties of young osteoblasts in vitro. Bone mineral content (BMC) and bone mineral density (BMD) were measured by ash weight and dual-energy X-ray absorptiometry, respectively. Whereas BMC and BMD of human bone fragments, which were inoculated with aged osteoblasts in SCID mice, decreased with time, telomerized presenescent osteoblasts maintained the BMC and BMD of human bone fragments, indicating that telomerized and rejuvenated osteoblasts may be functional to prevent bone mass loss in vivo. In xenogenic transplants, telomerized osteoblasts generated more bone tissue with lamellar bone structure and cellular components, than did control osteoblasts. These findings suggest that telomerized/rejuvenated presenescent osteoblasts may be used in the development of tissue engineering or cell-based therapy for bone regeneration and repair.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4
Figure 5
Figure 6
Figure 7

Similar content being viewed by others

References

  1. Blackburn EH . Structure and function of telomeres. Nature 1991; 350: 569–573.

    Article  CAS  PubMed  Google Scholar 

  2. Lindsey J et al. In vivo loss of telomeric repeats with age in humans. Mutat Res 1991; 256: 45–48.

    Article  CAS  PubMed  Google Scholar 

  3. Vaziri H et al. Loss of telomeric DNA during aging of normal and trisomy 21 human lymphocytes. Am J Hum Genet 1993; 52: 661–667.

    CAS  PubMed  PubMed Central  Google Scholar 

  4. Harley CB, Futcher AB, Greider CW . Telomeres shorten during aging of human fibroblasts. Nature 1990; 345: 458–460.

    Article  CAS  PubMed  Google Scholar 

  5. Bodnar AG et al. Extension of life-span by introduction of telmerase into normal human cells. Science 1998; 279: 349–352.

    Article  CAS  PubMed  Google Scholar 

  6. Nakamura TM et al. Telomerase catalytic subunit homologs from fission yeast and human. Science 1997; 277: 955–959.

    Article  CAS  PubMed  Google Scholar 

  7. Meyerson M et al. hEST2, the putative human telomerase catalytic subunit gene is up-regulated in tumor cells and during immortalization. Cell 1997; 90: 785–795.

    Article  CAS  PubMed  Google Scholar 

  8. Harrington L et al. Human telomerase contains evolutionarily conserved catalytic and structural subunits. Gene Dev 1997; 11: 3109–3115.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  9. Kilian A et al. Isolation of a candidate human telomerase catalytic subunit gene, which reveals complex splicing patterns in different cell types. Hum Mol Genet 1997; 6: 2011–2019.

    Article  CAS  PubMed  Google Scholar 

  10. Jiang X-R et al. Telomerase expression in human somatic cells does not induce charges associated with a transformed phenotype. Nat Genet 1999; 21: 111–113.

    Article  CAS  PubMed  Google Scholar 

  11. Morales CM et al. Absence of cancer-associated changes in human fibroblasts immortalized with telomerase. Nat Genet 1999; 21: 115–118.

    Article  CAS  PubMed  Google Scholar 

  12. Shi S et al. Bone formation by human postnatal bone marrow stromal stem cells is enhanced by telomerase expression. Nat Biotechnol 2002; 20: 587–591.

    Article  CAS  PubMed  Google Scholar 

  13. Yudoh K et al. Reconstituting telomerase activity using the telomerase catalytic subunit prevents the telomere shorting and replicative senescence in human osteoblasts. J Bone Miner Res 2001; 16: 1453–1464.

    Article  CAS  PubMed  Google Scholar 

  14. Shay JW, Wright WE . The use of telomerized cells for tissue engineering. Nat Biotechnol 2000; 18: 22–23.

    Article  CAS  PubMed  Google Scholar 

  15. Thomas M, Yang L, Hornsby PJ . Formation of functional tissue from transplanted adrenocortical cells expressing telomerase reverse transcriptase. Nat Biotechnol 2000; 18: 39–42.

    Article  CAS  PubMed  Google Scholar 

  16. Kiyono T et al. Both Rb/p16 INK 4a inactivation and telomerase activity are required to immortalize human epithelial cells. Nature 1998; 396: 84–88.

    Article  CAS  PubMed  Google Scholar 

  17. Counter CM et al. Dissociation among in vitro telomerase activity, telomere maintenance, and cellular immortalization. Proc Natl Acad Sci USA 1998; 95: 14723–14728.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  18. Seigneurin-Venin S, Bernard V, Tremblay JP . Telomerase allows the immortalization of T antigen-positive DMD myoblasts: a new source of cells for gene transfer application. Gene Therapy 2000; 7: 619–623.

    Article  CAS  PubMed  Google Scholar 

  19. Zhu J, Wang H, Bishop JM, Blackburn EH . Telomerase extends the lifespan of virus-transformed human cells without net telomere lengthening. Proc Natl Acad Sci USA 1999; 96: 3723–3728.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  20. Halvorsen TL, Leibowitz G, Levine F . Telomerase activity is sufficient to allow transformed cells to escape from crisis. Mol Cell Biol 1999; 19: 1864–1870.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  21. Darimont C et al. SV40 T antigen and telomerase are required to obtain immortalized human adult bone cells without loss of the differentiated phenotype. Cell Growth Differ 2002; 13: 59–67.

    CAS  PubMed  Google Scholar 

  22. Martinez ME et al. Influence of skeletal site of origin and donor age on osteoblastic cell growth and differentiation. Calcif Tissue Int 1999; 261: 280–286.

    Google Scholar 

  23. Jilka RL et al. Increased bone formation by prevention of osteoblast apoptosis with parathyroid hormone. J Clin Invest 1999; 104: 439–446.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  24. Pfeilschifter J et al. Mitogenic responsiveness of human bone cells in vitro to hormones and growth factors decreases with age. J Bone Miner Res 1993; 8: 707–717.

    Article  CAS  PubMed  Google Scholar 

  25. Sabokbar A, Millett PJ, Myer B, Rushton N . A rapid quantitative assay for measuring alkaline phosphatase activity in osteoblastic cells in vitro. Bone Miner 1994; 27: 57–67.

    Article  CAS  PubMed  Google Scholar 

  26. Smith JR, Braunschweiger KI . Growth of human embryonic fibroblasts at clonal density: concordance with results from mass cultures. J Cell Physiol 1978; 98: 597–602.

    Article  Google Scholar 

  27. Kim NW et al. Specific association of human telomerase activity with immortal cells and cancer. Science 1994; 266: 2011–2015.

    Article  CAS  PubMed  Google Scholar 

  28. Masuda H et al. Bone mass loss due to estrogen deficiency is compensated in transgenic mice overexpressing human osteoblast stimulating factor-1. Biochem Biophys Res Commun 1997; 238: 528–533.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Bioregulation, Institute of Medical Science, St. Marianna University, Miyamae-ku, Kawasaki City, Japan

    K Yudoh & K Nishioka

Authors
  1. K Yudoh
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. K Nishioka
    View author publications

    You can also search for this author in PubMed Google Scholar

Additional information

Supported by a Grant in Aid for Fundamental Comprehensive Research on Long-term Chronic Disease (Department of Rheumatoid Arthritis) from the Japanese Ministry of Health & Welfare

Rights and permissions

Reprints and permissions

About this article

Cite this article

Yudoh, K., Nishioka, K. Telomerized presenescent osteoblasts prevent bone mass loss in vivo. Gene Ther 11, 909–915 (2004). https://doi.org/10.1038/sj.gt.3302234

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.gt.3302234

Keywords

This article is cited by

Search

Advanced search

Quick links